March 30, 2021 | Vensana in the News
NVCA Policy Pulse: Medical Device Coverage Reform with Vensana’s Justin Klein & Kirk Nielsen
Read More
Our Latest
February 22, 2021 | Portfolio News
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Read More
February 9, 2021 | Events
Webinar: How Medtech Can Sustain Its Momentum in 2021: Strategies for Successful Investment, Co-Moderated by Justin Klein
Read More
January 7, 2021 | Portfolio News
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Read More
October 29, 2020 | Portfolio News
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Read More
September 7, 2020 | Portfolio News
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
Read More
July 8, 2020 | Portfolio News
CVRx® Raises $50 Million in New Equity Financing
Read More
June 15, 2020 | Events
Klein to speak at Life Sciences Future – MedTech
Read More
June 4, 2020 | Vensana in the News
Eight VCs Join NVCA Board and Barry Eggers of Lightspeed Appointed Chair
Read More
April 2, 2020 | Portfolio News
GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures
Read More
February 27, 2020 | Vensana in the News
Vensana—Is Medtech Investing on the Rebound?
Read More
October 8, 2019 | Vensana in the News
Medtech investor duo seeks to ‘fill the gap’ in device sector private funding
Read More
September 23, 2019 | Vensana in the News
New Minnesota-based fund has $225 million to invest in young med-tech companies
Read More
September 5, 2019 | Vensana in the News
New med-tech investment firm Vensana Capital launches $225 million fund
Read More
September 5, 2019 | Vensana in the News
Minneapolis-based Vensana Unveils $225 Million Venture Capital Fund
Read More
September 4, 2019 | Vensana in the News
Co-founded by Versant, NEA investors, new medtech VC firm kicks off inaugural fund with $225M bounty
Read More
September 4, 2019 | Vensana in the News
New Medtech Investor Vensana Closes $225 Million Debut Fund
Read More
September 4, 2019 | Press Releases
Vensana Capital Launches with Inaugural $225 Million Fund
Read More
September 4, 2019 | Vensana in the News
Podcast: Medtech VCs Klein, Nielsen Explain Why They Decided to Start Up Their Own Venture Firm, Vensana
Read More
August 12, 2019 | Events
Kirk Nielsen featured at MedTech Strategist Medical Alley Innovation Summit 2019
Read More
August 12, 2019 | Events
Vensana Capital Co-Organizes 26th Annual Phoenix Conference
Read More
June 14, 2019 | Events
TEDCO to Host Entrepreneur Expo on October 29 – Vensana Capital’s Justin Klein and AllegisCyber’s Bob Ackerman morning keynotes at the Expo
TEDCO’s annual Entrepreneur Expo was established to spotlight entrepreneurship in the region by bringing together Maryland’s various resources for a day of celebration.
Read More
June 10, 2019 | Events
Justin Klein featured at Virginia Bio Insights at University of Virginia Darden School of Business
Read More
May 31, 2019 | Portfolio News
Two medical device makers in Wayne get big boosts
Read More
May 30, 2019 | Portfolio News
Wayne medical device developer and its spin-off reel in $62 million
Read More
May 29, 2019 | Events
Kirk Nielsen to Co-Chair 2019 Medtech Investing Conference
Read More
May 29, 2019 | Portfolio News
Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™
Read More
May 29, 2019 | Portfolio News
Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®
Read More
May 29, 2019 | Portfolio News
Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases
Read More
May 13, 2019 | Events
Justin Klein featured at Pittsburgh Life Sciences Week 2019
Read More
May 2, 2019 | Events
Vensana Capital’s Cynthia Yee Keynotes Mayo Clinic and ASU MedTech Accelerator Investor Day: “Developing an ecosystem: strategies for assessing and mitigating risk in medtech investments.“
Read More
March 4, 2019 | Vensana in the News
Medical Device Investors Form New Medtech Venture Firm
Read More
